These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11. Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551 [TBL] [Abstract][Full Text] [Related]
43. Genetic analysis of two Indian families affected with congenital hereditary endothelial dystrophy: two novel mutations in SLC4A11. Kumar A; Bhattacharjee S; Prakash DR; Sadanand CS Mol Vis; 2007 Jan; 13():39-46. PubMed ID: 17262014 [TBL] [Abstract][Full Text] [Related]
45. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Vithana EN; Morgan PE; Ramprasad V; Tan DT; Yong VH; Venkataraman D; Venkatraman A; Yam GH; Nagasamy S; Law RW; Rajagopal R; Pang CP; Kumaramanickevel G; Casey JR; Aung T Hum Mol Genet; 2008 Mar; 17(5):656-66. PubMed ID: 18024964 [TBL] [Abstract][Full Text] [Related]
46. Human Corneal Expression of SLC4A11, a Gene Mutated in Endothelial Corneal Dystrophies. Malhotra D; Loganathan SK; Chiu AM; Lukowski CM; Casey JR Sci Rep; 2019 Jul; 9(1):9681. PubMed ID: 31273259 [TBL] [Abstract][Full Text] [Related]
47. SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress. Guha S; Chaurasia S; Ramachandran C; Roy S Sci Rep; 2017 Jun; 7(1):4074. PubMed ID: 28642546 [TBL] [Abstract][Full Text] [Related]
48. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations. Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594 [TBL] [Abstract][Full Text] [Related]
49. Congenital Corneal Endothelial Dystrophies Resulting From Novel De Novo Mutations. Cunnusamy K; Bowman CB; Beebe W; Gong X; Hogan RN; Mootha VV Cornea; 2016 Feb; 35(2):281-5. PubMed ID: 26619383 [TBL] [Abstract][Full Text] [Related]
50. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy. Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972 [TBL] [Abstract][Full Text] [Related]
51. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies. Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032 [TBL] [Abstract][Full Text] [Related]
52. Slc4a11 gene disruption in mice: cellular targets of sensorineuronal abnormalities. Lopez IA; Rosenblatt MI; Kim C; Galbraith GC; Jones SM; Kao L; Newman D; Liu W; Yeh S; Pushkin A; Abuladze N; Kurtz I J Biol Chem; 2009 Sep; 284(39):26882-96. PubMed ID: 19586905 [TBL] [Abstract][Full Text] [Related]
53. Biosynthetic and functional defects in newly identified SLC4A11 mutants and absence of COL8A2 mutations in Fuchs endothelial corneal dystrophy. Soumittra N; Loganathan SK; Madhavan D; Ramprasad VL; Arokiasamy T; Sumathi S; Karthiyayini T; Rachapalli SR; Kumaramanickavel G; Casey JR; Rajagopal R J Hum Genet; 2014 Aug; 59(8):444-53. PubMed ID: 25007886 [TBL] [Abstract][Full Text] [Related]
54. Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies. Loganathan SK; Schneider HP; Morgan PE; Deitmer JW; Casey JR Am J Physiol Cell Physiol; 2016 Nov; 311(5):C735-C748. PubMed ID: 27558157 [TBL] [Abstract][Full Text] [Related]